<DOC>
	<DOC>NCT00198536</DOC>
	<brief_summary>The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome</brief_summary>
	<brief_title>Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Ecabet</mesh_term>
	<criteria>Agree to avoid systemic &amp; topical ophthalmic meds &amp; disallowed meds Have a best corrected visual acuity (BCVA) of 20/40 with pinhole or better in each eye Diagnosis of moderate dry eye syndrome Uncontrolled ocular or systemic disease that could interfere with study Diagnosis of Sjogren's syndrome, lacrimal obstruction, reflex, lidrelated or contact lensrelated dry eye syndrome(DES); significant anterior blepharitis or meibomianitis Contraindications or hypersensitivity to use of study meds or components Wear contact lenses Secondary dry eye to surgery Eye surgery (including laser) within 6 months Use of systemic or topical ophthalmic meds within 14 days Punctal plugs in one or both eyes in place for &lt;45 days Permanent occlusion of the lacrimal puncta</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>